Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2025-03-13 00:00:00 ET · period of report 2025-03-11 · accession 0001171843-25-001470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-13 | 2025-03-11 | ANIK | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | +2,561 | 18.8K | +16% | $0 |
| D | 2025-03-13 | 2025-03-11 | ANIK | Nunes Anne | SVP, Chief Ops Off | F - Tax | $16.79 | -752 | 18.1K | -4% | -$12.6K |
| D | 2025-03-13 | 2025-03-11 | ANIK | Nunes Anne | SVP, Chief Ops Off | M - OptEx | $0.00 | -2,561 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-11 | M | A | 2,561 | $0.00 | 18,837 | D | — | — | (F1) Reflects the third and final vesting installment of RSUs granted on March 11, 2022. |
| 2 | Common | Common Stock | 2025-03-11 | F | D | 752 | $16.79 | 18,085 | D | — | — | (F2) Reflects an aggregate of 752 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 11, 2025. (F3) Reflects the closing price of ANIK common stock on March 11, 2025, the trading day to which the vesting of RSUs gave rise to tax withholding obligations. |
| 3 | Derivative | Restricted Stock Unit | 2025-03-11 | M | D | 2,561 | $0.00 | 0 | D | $0.00 · — to — | 2,561 Common Stock | (F4) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 11, 2023. |